355 related articles for article (PubMed ID: 33367746)
1. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.
Carrillo-López N; Martínez-Arias L; Alonso-Montes C; Martín-Carro B; Martín-Vírgala J; Ruiz-Ortega M; Fernández-Martín JL; Dusso AS; Rodriguez-García M; Naves-Díaz M; Cannata-Andía JB; Panizo S
Nephrol Dial Transplant; 2021 Mar; 36(4):618-631. PubMed ID: 33367746
[TBL] [Abstract][Full Text] [Related]
2. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.
Fernández-Villabrille S; Martín-Vírgala J; Martín-Carro B; Baena-Huerta F; González-García N; Gil-Peña H; Rodríguez-García M; Fernández-Gómez JM; Fernández-Martín JL; Alonso-Montes C; Naves-Díaz M; Carrillo-López N; Panizo S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891922
[TBL] [Abstract][Full Text] [Related]
3. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
5. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.
Lee SK; Lorenzo JA
Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442
[TBL] [Abstract][Full Text] [Related]
6. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
[TBL] [Abstract][Full Text] [Related]
7. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
[TBL] [Abstract][Full Text] [Related]
8. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M
J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764
[TBL] [Abstract][Full Text] [Related]
9. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.
Lee GL; Yeh CC; Wu JY; Lin HC; Wang YF; Kuo YY; Hsieh YT; Hsu YJ; Kuo CC
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):432-445. PubMed ID: 30626205
[TBL] [Abstract][Full Text] [Related]
10. TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
Di Bartolo BA; Cartland SP; Harith HH; Bobryshev YV; Schoppet M; Kavurma MM
PLoS One; 2013; 8(9):e74211. PubMed ID: 24040204
[TBL] [Abstract][Full Text] [Related]
11. Serum PTH, PTH1R/ATF4 pathway, and the sRANKL/OPG system in bone as a new link between bone growth, cross-sectional geometry, and strength in young rats with experimental chronic kidney disease.
Sieklucka B; Pawlak D; Domaniewski T; Hermanowicz J; Lipowicz P; Doroszko M; Pawlak K
Cytokine; 2021 Dec; 148():155685. PubMed ID: 34411988
[TBL] [Abstract][Full Text] [Related]
12. The function and meaning of receptor activator of NF-κB ligand in arterial calcification.
Nie B; Zhou SQ; Fang X; Zhang SY; Guan SM
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):666-671. PubMed ID: 26489619
[TBL] [Abstract][Full Text] [Related]
13. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.
Nie B; Zhang SY; Guan SM; Zhou SQ; Fang X
Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488
[TBL] [Abstract][Full Text] [Related]
14. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
15. Effects of the administration of corticosterone, parathyroid hormone, or both, and of their withdrawal, on rat bone and cartilage histomorphometric parameters, and on osteoprotegerin and RANKL mRNA expression and proteins.
Silvestrini G; Ballanti P; Leopizzi M; Gualtieri N; Sardella D; Monnazzi P; Simeoni S; Sebastiani M; Bonucci E; Patacchioli FR
J Mol Histol; 2007 Jun; 38(3):215-26. PubMed ID: 17476578
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
Zhao L; Li M; Sun H
J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
[TBL] [Abstract][Full Text] [Related]
17. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.
Carrillo-López N; Martínez-Arias L; Fernández-Villabrille S; Ruiz-Torres MP; Dusso A; Cannata-Andía JB; Naves-Díaz M; Panizo S;
Calcif Tissue Int; 2021 Apr; 108(4):439-451. PubMed ID: 33586001
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147
[TBL] [Abstract][Full Text] [Related]
19. PTH differentially regulates expression of RANKL and OPG.
Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA
J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393
[TBL] [Abstract][Full Text] [Related]
20. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.
Yang Y; Blair HC; Shapiro IM; Wang B
J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
